This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

The Role of Neurobiologic Processes in Treating Depression

Michael E. Thase, MD

Published: October 15, 2010

Article Abstract

Current antidepressants work by directly affecting the neurotransmission of serotonin and norepinephrine. These neurotransmitters modulate regions of the brain associated with depression and affect the expression of genes involved in neurogenesis and neuroprotection. Treatment targets for the development of future antidepressants include medications with novel mechanisms of action, such as glutamate receptor antagonists, that may alter the stress response of gene activity and provide neuroprotection to patients with depression.

See the entire activity.


Related Articles

Volume: 71

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...